Purdue Pharma, maker of OxyContin, expected to plead guilty to charges related to nation’s opioid crisis
The guilty plea is part of a settlement with the Justice Department.
Purdue Pharma is expected Tuesday to plead guilty to federal conspiracy and kickback charges and acknowledge that its aggressive marketing of opioids over the last three decades helped propel an addiction crisis that killed hundreds of thousands of Americans.
The guilty plea is part of a settlement with the Justice Department. Critics say that a separate deal with members of the Sackler family, who owned the company and made an estimated $10 billion from OxyContin, is too lenient since they will not admit to wrongdoing and face zero charges as part of the settlement.
Purdue Pharma said it knowingly and willfully offered payments…